Curcumin pharmaceutical preparation
A technology for curcumin and medicine, applied in the field of novel curcumin pharmaceutical preparations, can solve the problems of low bioavailability, very sensitive to light, poor permeability and the like
Inactive Publication Date: 2017-11-03
SUZHOU AUZONE BIOLOGICAL TECH CO LTD
View PDF6 Cites 29 Cited by
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
[0006] In order to develop curcumin as a clinical drug, an ideal formulation should address the following issues: poor solubility, chemical stability (hydrolysis, oxidation, heat and light) and pharmacokinetic properties, including absorption, distribution, metabolism and elimination in vivo, bioavailability Low concentration, poor permeability, short half-life, poor local delivery of curcumin to therapeutic targets
A small number of studies have also involved protection from light, and being very sensitive to light could be one of the major problems in the commercial development of a drug
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View moreImage
Smart Image Click on the blue labels to locate them in the text.
Smart ImageViewing Examples
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 3
[0077] Example 3: Micellar formulations
[0078] Element
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More PUM
Login to View More
Abstract
The present invention belongs to the field of medicine, and particularly relates to a novel curcumin pharmaceutical preparation, which comprises a solid dispersion, a micellar preparation, SMEDDS and a nanometer emulsion. According to the present invention, by increasing the solubility and the bioavailability of curcumin, the curcumin pharmaceutical preparation can effectively utilize the pharmacological effects of anti-oxidation, anti-inflammation, anti-cancer, apoptosis induction, antiangiogenesis, neuroprotection, anti-microorganism, liver and kidney protection, vascular formation inhibition, myocardial infarction prevention, blood glucose lowering, anti-rheumatism and the like of the curcumin.
Description
technical field [0001] The present invention belongs to the field of medicine. In particular, the present invention relates to novel curcumin pharmaceutical preparations. The new preparation can more effectively utilize curcumin for anti-oxidation, anti-inflammation, anti-cancer, induction of apoptosis, anti-angiogenesis, neuroprotection, anti-microbial, liver and kidney protection, inhibition of angiogenesis, prevention of myocardial infarction, hypoglycemia, Anti-rheumatic and other pharmacological effects. Background technique [0002] Curcumin is undoubtedly one of the most biologically active molecules found in nature so far. Curcumin interacts with a large number of intracellular and extracellular targets in a biphasic dose-dependent manner. It controls inflammation, oxidative stress, cell survival, cell secretion, homeostasis and proliferation. Its mechanism of action is broadly directed toward cells in an abnormal state exhibiting disordered physiology or overt m...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More Application Information
Patent Timeline
Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K9/51A61K9/14A61K9/107A61K9/127A61K31/12A61K47/34A61P29/00A61P35/00A61P39/06A61P25/00A61P9/10A61P3/10
CPCA61K9/1075A61K9/127A61K9/146A61K9/5146A61K31/12A61K47/34
Inventor 周新富
Owner SUZHOU AUZONE BIOLOGICAL TECH CO LTD
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Eureka Blog
Learn More Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com